This candidate will be personally engaged in, and supervise, a small team of less than 5 individuals, in the areas of HSC propagation and differentiation, will have a proven track-record evidenced by publications in genome editing of stem cells to generate and/or correct disease models, and possess expertise in HSC biology. Candidates may be from a basic research or clinical background. The team will work to generate disease models, build and test new genome editing constructs, establish human HSC cultures from embryonic stem cells or induced pluripotent stem cells, from patient samples and test applications of genome and base editing to achieve disease correction in human HSC. This individual will also work closely with other genome editing and active genetics groups at TIGS to integrate new advances in this area.
source https://www.pharmatutor.org/content/october-2019/tetley-and-lupton-scholarships-2020
No comments:
Post a Comment